Literature DB >> 21874757

Acquired hemophilia A.

Massimo Franchini1, Giuseppe Lippi.   

Abstract

Acquired hemophilia A is a rare but often life-threatening hemorrhagic disorder characterized by an autoantibody directed against coagulation factor VIII. Fifty per cent of cases are idiopathic whereas the remaining 50% are associated with pregnancy, autoimmune conditions, malignancies and drugs. In this review the actual knowledge on diagnostic and therapeutic aspects of this disease will be summarized.

Entities:  

Mesh：

Year:  2011        PMID： 21874757     DOI： 10.1016/b978-0-12-387025-4.00003-0

Source DB:  PubMed          Journal:  Adv Clin Chem        ISSN： 0065-2423            Impact factor:   5.394


  4 in total

1.  Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management.

Authors:  Massimo Franchini; Giancarlo Castaman; Antonio Coppola; Cristina Santoro; Ezio Zanon; Giovanni Di Minno; Massimo Morfini; Elena Santagostino; Angiola Rocino
Journal:  Blood Transfus       Date:  2015-06-24       Impact factor: 3.443

2.  [Spontaneous hematoma and hip pain in a 65-year old patient].

Authors:  C Sucker; S Korfmacher; M Papp-Váry; C Grieser; H Riess
Journal:  Internist (Berl)       Date:  2012-10       Impact factor: 0.743

3.  Acquired Hemophilia A and urothelial carcinoma.

Authors:  Fadi Taza; Nawar Suleman; Robert Paz; Christopher Haas
Journal:  J Community Hosp Intern Med Perspect       Date:  2021-01-26

Review 4.  Acquired hemophilia A (AHA): underreported, underdiagnosed, undertreated medical condition.

Authors:  Doaa M El Demerdash; Alia Ayad; Noha Tawfik
Journal:  Egypt J Intern Med       Date:  2022-01-25
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.